Search
for
Sort by
Research 421–450 of 1000+
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- JunB defines functional and structural integrity of the epidermo-pilosebaceous unit in the skin
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- The Polycystic Ovary Syndrome Evolutionary Paradox: a Genome-Wide Association Studies–Based, in silico, Evolutionary Explanation
- Idiopathic Hirsutism*
- Hormonal treatment of acne vulgaris: an update
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Combined hormonal contraception and venous thromboembolism
- Biology of Hair Growth
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Androgen receptor gene polymorphism and polycystic ovary syndrome
- Preparation and characterization of Betasitosterol-loaded nanostructured lipid carriers for butter enrichment
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Evidence-based approach to cutaneous hyperandrogenism in women
- Mood disorders and quality of life in polycystic ovary syndrome
- A Mouse Model of Androgenetic Alopecia
- Recent advances in oxasteroids chemistry
- Androgens and Antiandrogens
- Cutaneous Side Effects of Oral Contraceptives
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism